Establishment of MAIDS-defective virus-infected B cell lines and their characterization.
Mice inoculated with the murine AIDS (MAIDS)-defective virus develop severe B and T cell dysfunctions. The primary event in the development of this disease is the infection and polyclonal expansion of the target cells of this defective virus, which have been reported to belong to the B cell lineage. To further study the central role that these cells play in the development of MAIDS, we attempted to establish MAIDS-defective virus-infected B cell lines in vitro. We succeeded in establishing two cell lines, SD1 and CSTB5, from the enlarged organs of C57BL/6 mice inoculated with helper-free stocks of the MAIDS-defective virus. Both cell lines are not transplantable in syngeneic C57BL/6 mice or in nude or CD8-/- mice and are apparently not malignant. They both belong to the B lineage, as their immunoglobulin (Ig) genes, but not the T cell receptor (TcR) beta locus, are rearranged, suggesting that they are relatively mature B cells. However, analysis of cell surface marker expression by FACS revealed a surface phenotype similar to that of pre-B cells (MHC I+, MHC II+, B7.2+, sIgM-, sIgG-, kappa-, B220-, CD5-, Thy1.2-, TcR-, CD3-, CD4-, CD8-, Mac-1-, 33D1-). Additionally, the CSTB5 cells express CD40 and the SD1 cells express CD43. Both cell lines contain the MAIDS-defective provirus and express the expected 4.2-kb viral RNA and the corresponding Pr60gag protein. The CSTB5 cells are nonproducer, while the SD1 cell line produces what appears to be an endogenous MuLV. The phenotype of these cell lines is very similar to what is known about the target B cells of this virus in vivo. These new established cell lines are likely to be useful in elucidating the mechanism(s) by which the MAIDS-defective virus causes its target B cells to proliferate and induce T cell anergy in infected animals.
Klein
S J
SJ
Laboratory of Molecular Biology, Clinical Research Institute of Montreal, Quebec, Canada.
Simard
C
C
Jolicoeur
P
P
D000818:Animals; D001402:B-Lymphocytes / Q000276:immunology / Q000821:virology*; D002460:Cell Line; D003673:Defective Viruses / Q000276:immunology / Q000472:pathogenicity*; D015683:Gene Products, gag / Q000235:genetics; D015326:Gene Rearrangement, B-Lymphocyte, Heavy Chain; D009052:Leukemia Virus, Murine / Q000276:immunology / Q000472:pathogenicity*; D008213:Lymphocyte Activation; D008221:Lymphoid Tissue / Q000276:immunology / Q000821:virology; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D008819:Mice, Nude; D016513:Mice, SCID; D016183:Murine Acquired Immunodeficiency Syndrome / Q000209:etiology* / Q000276:immunology / Q000821:virology; D011533:Proviruses / Q000276:immunology / Q000472:pathogenicity; D014764:Viral Proteins / Q000235:genetics
D015683:Gene Products, gag; C107020:Pr60(gag) protein, murine AIDS virus; D014764:Viral Proteins